tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GKOS Stock Latest News

Glaukos price target raised to $125 from $113 at Citi
The FlyGlaukos price target raised to $125 from $113 at Citi
1d ago
GKOS
Glaukos price target raised to $125 from $117 at Needham
PremiumThe Fly
Glaukos price target raised to $125 from $117 at Needham
3d ago
GKOS
Positive Outlook for Glaukos: Buy Rating Reinforced by Epioxa’s Market Potential and Increased Price Target
PremiumRatings
Positive Outlook for Glaukos: Buy Rating Reinforced by Epioxa’s Market Potential and Increased Price Target
3d ago
GKOS
Glaukos Highlights Innovation in November 2025 Presentation
PremiumCompany Announcements
Glaukos Highlights Innovation in November 2025 Presentation
1M ago
8K
GKOS
Beaten Down by 35%-Plus: Analysts Say These 2 Oversold Stocks Are Poised to Turn the Corner
PremiumStock Analysis & Ideas
Beaten Down by 35%-Plus: Analysts Say These 2 Oversold Stocks Are Poised to Turn the Corner
1M ago
GKOS
XNCR
Glaukos Corp. Reports Record Sales and FDA Approval
PremiumCompany AnnouncementsGlaukos Corp. Reports Record Sales and FDA Approval
1M ago
GKOS
Midday Fly By: Big Tech reports, Novo tops Pfizer bid for Metsera
Premium
The Fly
Midday Fly By: Big Tech reports, Novo tops Pfizer bid for Metsera
1M ago
BA
CI
Glaukos rises 27.5%
Premium
The Fly
Glaukos rises 27.5%
1M ago
GKOS
Glaukos price target raised to $120 from $110 at JPMorgan
PremiumThe Fly
Glaukos price target raised to $120 from $110 at JPMorgan
1M ago
GKOS
Glaukos price target raised to $113 from $110 at Citi
PremiumThe Fly
Glaukos price target raised to $113 from $110 at Citi
1M ago
GKOS
Glaukos price target raised to $116 from $104 at BTIG
PremiumThe Fly
Glaukos price target raised to $116 from $104 at BTIG
1M ago
GKOS
Cautious Outlook for Glaukos Amid Regulatory Uncertainty and Valuation Concerns
PremiumRatings
Cautious Outlook for Glaukos Amid Regulatory Uncertainty and Valuation Concerns
1M ago
GKOS
Glaukos price target raised to $122 from $120 at Wells Fargo
PremiumThe FlyGlaukos price target raised to $122 from $120 at Wells Fargo
1M ago
GKOS
Strong Buy Rating for Glaukos Driven by iDose Success and Positive Revenue Projections
Premium
Ratings
Strong Buy Rating for Glaukos Driven by iDose Success and Positive Revenue Projections
1M ago
GKOS
Glaukos’s Strong Growth Prospects: Buy Rating Affirmed Amid Surpassing Sales and Promising Pipeline
Premium
Ratings
Glaukos’s Strong Growth Prospects: Buy Rating Affirmed Amid Surpassing Sales and Promising Pipeline
1M ago
GKOS
Glaukos Corp. Reports Record Q3 Sales Growth
PremiumCompany Announcements
Glaukos Corp. Reports Record Q3 Sales Growth
1M ago
GKOS
Closing Bell Movers: Meta sinks, Alphabet jumps after earnings
PremiumThe Fly
Closing Bell Movers: Meta sinks, Alphabet jumps after earnings
1M ago
GH
PI
Glaukos Reports Record Q3 2025 Sales Growth
PremiumCompany Announcements
Glaukos Reports Record Q3 2025 Sales Growth
1M ago
8K
GKOS
Glaukos reports Q3 EPS (16c), consensus (26c)
PremiumThe Fly
Glaukos reports Q3 EPS (16c), consensus (26c)
1M ago
GKOS
Glaukos sees FY25 revenue $490M-$495M, consensus $484.6M
PremiumThe FlyGlaukos sees FY25 revenue $490M-$495M, consensus $484.6M
1M ago
GKOS
Glaukos sees FY26 revenue $600M-$620M, consensus $608.1M
Premium
The Fly
Glaukos sees FY26 revenue $600M-$620M, consensus $608.1M
1M ago
GKOS
Glaukos Corp. Advances NEXAGON® Study for Eye Condition Treatment
Premium
Company Announcements
Glaukos Corp. Advances NEXAGON® Study for Eye Condition Treatment
2M ago
GKOS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >